Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19580582rdf:typepubmed:Citationlld:pubmed
pubmed-article:19580582lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:19580582lifeskim:mentionsumls-concept:C0406317lld:lifeskim
pubmed-article:19580582lifeskim:mentionsumls-concept:C0205234lld:lifeskim
pubmed-article:19580582pubmed:issue4lld:pubmed
pubmed-article:19580582pubmed:dateCreated2009-7-7lld:pubmed
pubmed-article:19580582pubmed:abstractTextSkin irradiation with ultraviolet light B (UV-B) and in particular the emission peak at 311 nm represents an effective therapeutic regimen for psoriasis. Excessive tanning, photoaging, and skin cancerization do occur mainly in subjects with skin phototype I to III. The possibility of developing skin cancer is parallel to the skin surface area under treatment and to the overall irradiation dose. We report here on a new focused phototherapy method releasing UV-B with a peak at 311 nm, which consists in the selective irradiation of single psoriatic patches with a new device equipped with a special optic fiber. The treatment is effective, safe and well tolerated. Psoriasis Area and Severity Index 75 is achieved in 64% of patients after 12 sessions of treatment. The Physician Global Assessment evaluation significantly improves in all treated patients.lld:pubmed
pubmed-article:19580582pubmed:languageenglld:pubmed
pubmed-article:19580582pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19580582pubmed:citationSubsetIMlld:pubmed
pubmed-article:19580582pubmed:statusMEDLINElld:pubmed
pubmed-article:19580582pubmed:issn1529-8019lld:pubmed
pubmed-article:19580582pubmed:authorpubmed-author:LottiTorelloTlld:pubmed
pubmed-article:19580582pubmed:authorpubmed-author:De...lld:pubmed
pubmed-article:19580582pubmed:authorpubmed-author:BuggianiGiona...lld:pubmed
pubmed-article:19580582pubmed:authorpubmed-author:GrazziniMarta...lld:pubmed
pubmed-article:19580582pubmed:authorpubmed-author:TripoLaraLlld:pubmed
pubmed-article:19580582pubmed:authorpubmed-author:KrysenkaAlena...lld:pubmed
pubmed-article:19580582pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19580582pubmed:volume22lld:pubmed
pubmed-article:19580582pubmed:ownerNLMlld:pubmed
pubmed-article:19580582pubmed:authorsCompleteYlld:pubmed
pubmed-article:19580582pubmed:pagination383-5lld:pubmed
pubmed-article:19580582pubmed:meshHeadingpubmed-meshheading:19580582...lld:pubmed
pubmed-article:19580582pubmed:meshHeadingpubmed-meshheading:19580582...lld:pubmed
pubmed-article:19580582pubmed:meshHeadingpubmed-meshheading:19580582...lld:pubmed
pubmed-article:19580582pubmed:meshHeadingpubmed-meshheading:19580582...lld:pubmed
pubmed-article:19580582pubmed:meshHeadingpubmed-meshheading:19580582...lld:pubmed
pubmed-article:19580582pubmed:meshHeadingpubmed-meshheading:19580582...lld:pubmed
pubmed-article:19580582pubmed:meshHeadingpubmed-meshheading:19580582...lld:pubmed
pubmed-article:19580582pubmed:meshHeadingpubmed-meshheading:19580582...lld:pubmed
pubmed-article:19580582pubmed:meshHeadingpubmed-meshheading:19580582...lld:pubmed
pubmed-article:19580582pubmed:meshHeadingpubmed-meshheading:19580582...lld:pubmed
pubmed-article:19580582pubmed:articleTitleFocused UV-B narrowband microphototherapy (Biopsorin). A new treatment for plaque psoriasis.lld:pubmed
pubmed-article:19580582pubmed:affiliationUniversity Unit of Dermatology, University of Florence School of Medicine, Florence, Italy. tlotti@unifi.itlld:pubmed
pubmed-article:19580582pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19580582pubmed:publicationTypeClinical Triallld:pubmed